scapulo-humero-peroneal distribution; prominent contractures of the ankle, elbow, and spine; and heart issues. The cardiomyopathy and conduction defects may result in a high risk of cardiac sudden death. [7] [8] [9] LGMD1B is characterized by predominant scapular and pelvic girdle muscle involvement, and the onset age is later than that of EDMD. Joint contractures and restrictive neck flexions are not prominent in the early stage of the disease, in contrast to EDMD. [10, 11] L-CMD is described in patients whose symptoms manifest in the first few months of life or even during the prenatal period. [12, 13] Patients with L-CMD have delayed motor development, hypotonia, and proximal limb and cervical-axial muscle weakness. [14] In addition, strikingly, some patients present with dropped head syndrome. [15] Most patients are unable to walk or sit without assistant during childhood, and some even require early respiratory support or die due to cardiac involvement. [16, 17] The pathological diagnosis of L-CMD is difficult because the histological evidence of inflammation in laminopathies makes it difficult to distinguish from juvenile idiopathic inflammatory myopathy. [18] As reported in a previous articles, though these clinical features may be determined by the same LMNA mutation, it is not easy to distinguish according to the genotype. [11, 19] Muscle imaging has been reported as an important part of the diagnostic workup of myopathies in recent years. [20] [21] [22] [23] Magnetic resonance imaging (MRI) has excellent soft-tissue contrast and resolution, it is a safe and noninvasive method for studying and evaluating myopathy. [20, [24] [25] [26] It is, therefore, the method of detection of the changes, such as fatty infiltration into the muscle, that might serve as indications that differential diagnosis or the evaluation of the severity of the disease should be performed. It has been demonstrated that patients have a similar pattern of fatty infiltration regardless of whether their phenotype is EDMD or LGMD1B. [26] [27] [28] [29] Our objective was to investigate whether there is a consistent pattern of muscle MRI changes in patients with LMNA mutations related to EDMD, LGMD1B, and L-CMD. Moreover, we were dedicated to assessing the possibility of MRI scanning in distinguishing L-CMD from idiopathic inflammatory myopathy.
Methods

Ethical approval
The study was approved by the Ethics Committee of Peking University First Hospital, and written informed consent was obtained from all patients or their parents.
Patients
Twenty-two patients from twenty-one unrelated families with LMNA mutations were recruited from the Department of Neurology, Peking University First Hospital, between March 2012 and October 2017. Their clinical data were recorded, including age of onset; presenting features; joint contractures; muscle weakness involving cervical, proximal, and distal upper and lower limbs; and serum creatine kinase (CK) level [ Table 1 ]. Cardiac function was assessed via electrocardiograph (ECG), Holter or echocardiogram.
Muscle pathology
We also analyzed the musculoskeletal system via electromyography and muscle biopsy. All biopsied samples were taken from the biceps brachii or quadriceps. These fresh-frozen muscle specimens were fixed in liquid nitrogen precooled isopentane and were processed for histochemical staining, enzyme histochemical staining, and immunohistochemical staining with first antibodies against major histocompatibility complex 1, complement membrane attack complex, CD3, CD4, CD8, CD20, and CD68.
Genetic test
Genomic DNA was extracted from the blood of patients and their parents. For patients No. 2-4, 8, and 15-18, LMNA gene mutations were screened via direct sequencing of polymerase chain reaction (PCR) products. All the exons and intron/exons of the LMNA gene were PCR-amplified using oligonucleotide primer designed by Primer Premier 5.0 online software (Premier Biosoft International, Palo Alto, CA, USA). For other patients, targeted next-generation sequencing of a panel including muscular dystrophy and congenital myopathy was performed initially, followed by Sanger sequencing of suspicious mutations.
Muscle imaging
MRI examinations were performed on a 3.0T (GE Signa, USA or Philips Achieva, NED) scanner at the level of the thigh in all patients, as previously described. [23] Lower leg muscle MRI was performed in six patients, including one with EDMD, four with LGMD, and one with L-CMD. Follow-up MRI scans were performed for three patients (patients No. 15, 19, and 22) 1-3 years after the first MRI. The following sequences were used: (1) axial T1-weighted fast spin-echo series for fatty infiltration and (2) axial T2-weighted short-time inversion recovery series with fat suppression series for edema. The parameters used for the MRI sequences were repetition time (TR) = 450-480 ms, echo time (TE) = 20 ms, thickness = 5 mm, section interval = 1 mm, and field of view = 28-32 cm. Two independent observers (Y.Z and H.L), blind to clinical data, quantified the fatty muscle infiltration on the muscle MRI scans using the modified version of the Mercuri score [ Tables 2 and 3 ]. [29, 30] 
Statistical analysis
Data were analyzed using SPSS version 22.0 (SPSS Inc., Chicago, IL, USA). Mann-Whitney U-tests were conducted to assess the significance of the differences in the MRI fatty infiltration scores among the three phenotypes. Differences were considered statistically significant at P < 0.05 (two-tailed). Correlations between the summed scores from the MRI findings and clinical assessments (including disease duration and age of onset) and correlations between the summed scores of fatty infiltration and genotypes were analyzed with nonparametric Spearman's rank analyses.
Results
Clinical features
The study included 22 patients (11 males and 11 females)
[ Table 1 ]. The average age at onset was 4.8 ± 11. changes. The three groups could be distinguished according to their phenotype.
Group I: Emery-Dreifuss muscular dystrophy
Patients No. 1-5 belonged to the EDMD group and their ages range from 4.0 to 29.0 years. These patients demonstrated normal developmental motor milestones and presented with slowly progressing muscle weakness, involving both the humeral and peroneal muscles and early onset of knee and elbow contractures. They had difficulties in running, jumping, standing up from a squatting position, or going up and down stairs. Heart function assessed by ECG showed tachycardia in patient No. 5. Holter monitoring of patient No. 3 showed no sinus P-wave or F-wave; atrioventricular junctional escape rhythm; her average heart rate was 46 beats/min; and her echocardiography showed mild tricuspid reflux and pulmonary arterial hypertension. The suggestion of a cardiologist was to implant a pacemaker.
Group II: Limb-girdle muscular dystrophy type 1B Patients No. 6-14 belonged to the LGMD1B group, with ages ranging from 2.5 to 57.0 years. They showed scapular and girdle weakness at the onset of the disease and no evidence of joint contractures until the last interview, except for patients No. 12 and 13. Patient No. 10 had bradycardia, LGMD 1  1  2  2  1  1  1  3  3  3  None  11  LGMD  0  0  0  0  0  0  0  2  2  1  None  13 LGMD 
Myopathological findings
The histological findings from the muscle biopsies were not uniform and included muscular dystrophic changes in 18 patients, necrotizing myopathic changes in two patients, a nonspecific change in one patient, and end-stage changes in one patient. Notably, there were six L-CMD patients who showed muscular dystrophic change with multifocal inflammatory cell infiltration in the endomysium or in the perivascular region of the perimysium (patients No. 15, 17, 18, 20, 21, and 22) [ Figure 1 ].
Mutation analysis
The genetic and phenotypic data are summarized in Supplementary Table 1 754G>A, c.1152G>C,  c.1681C>G, c.827G>C, c.92_94del, c.770T>C, c.823C>G , and c.1478A>C) (according to http://www.dmd.nl/, the UMD-LMNA database and the HGMD pro-database). None of the mutations were found in their parents or immediate family members, except for patients No. 7, 13 and 14, which indicated that they occurred de novo.
Muscle magnetic resonance imaging findings
In total, 21 patients (four with EDMD, nine with LGMD1B, and eight with L-CMD) underwent thigh muscle MRI [ Figures 1, 2 and Tables 2, 3 ]. The mean fatty scores varied greatly among the different thigh muscles across the different phenotypes. The results showed that the adductor magnus, the semimembranosus, and the long and short heads of the biceps femoris were the most frequently involved muscles across the three phenotypes, while the gracilis and sartorius were less involved. The involvement of the vasti muscles (vastus lateralis, vastus intermedius, and vastus medialis), while sparing the rectus femoris, was remarkable. Statistically, we did not find any significant differences in the severity of the fatty muscle infiltration between the EDMD and LGMD1B phenotypes.
In the L-CMD patients, the results revealed that the adductor magnus, the semimembranosus, and the long and short heads of the biceps femoris were the most frequently involved muscles, while the gracilis and sartorius were less involved. Unlike EDMD and LGMD, we found infiltration of the vasti muscles in the early-stage L-CMD phenotype to a lesser degree [ Figures 1 and 3 ]. This difference was significantly different (vastus lateralis: Z = −2.691, f a e P = 0.007; vastus intermedius: Z = −2.520, P = 0.014; and vastus medialis: Z = −2.579, P = 0.011). However, in our follow-up research of some CMD patients, we observed fatty infiltration in the vasti muscle, with relative sparing of the rectus femoris during the course of the disease progression. The MRI demonstrated a pattern in which advanced-stage L-CMD presented in a similar manner as EDMD or LGMD. Hence, we speculated that the fatty infiltration scores of the vasti muscles were correlated with disease duration. The correlation between the mean score of the fatty infiltration of the vasti muscles and duration was analyzed with nonparametric Spearman's rank analyses. A significant difference was detected between the disease duration and mean scores of fatty infiltrations of the vasti muscles (r = 0.444, P = 0.026,). We used the linear regression method to determine the linear equation of the score of the vasti muscles and disease duration; the result revealed that the muscle score of the vasti muscle as (Y) = 1.483 + 0.075 × disease duration (X) [ Figure 4 ].
Of the six patients who exhibited massive inflammatory cell infiltration in their muscle biopsies, only one patients had a mild edema-like condition in the thigh [ Figure 1 ].
There were only six patients who underwent lower leg muscle MRI, including one with EDMD, four with LGMD1B, and one with L-CMD. We found that the soleus and the gastrocnemius medialis and lateralis were the muscles with the most severe fatty infiltration [ Figure 5 ].
dIscussIon
The present study contained different phenotypes of laminopathies. [31] The muscular dystrophies are a large group of genetic muscle disorders. [14, 27, 30] In general, different conditions often share similar clinical and histopathological phenotypes, so they are difficult to diagnose. The reliable method involves gene sequencing, but this method is expensive and time consuming. In recent years, there has been a great deal of encouraging data regarding the possible role of muscle imaging in identifying different muscular dystrophies. Some reported articles demonstrated a way to identify specific patterns in some muscular dystrophies, such as Ullrich congenital muscular dystrophy, [28, 32] Duchenne muscular dystrophy, [33, 34, 37] and other congenital muscular dystrophies. [34] This study provided additional useful information regarding the differential diagnosis of laminopathies from other muscle diseases.
The present study showed, via MRI, that patients with LMNA gene mutations share a characteristic pattern of muscle involvement. We concluded that the adductor magnus, the semimembranosus, and the long and short heads of the biceps femoris were the most frequently involved muscles across the three phenotypes. The rectus femoris, gracilis, and sartorius either mildly involved or not involved completely. This result was in accordance with previous reports. [27, 29, 35] In L-CMD, although the muscle MRI scans showed less fatty infiltration in the vasti muscles in the early stage of the disease, the follow-up MRI revealed fatty infiltration in the vasti muscle, while the rectus femoris was relatively spared, indicating the same muscle involvement pattern as that in EDMD or LGMD1B over the course of disease progression. Some previous researchs have suggested that L-CMD may progress to EDMD or LGMD1B. [11, 17] At the level of the lower leg, we also found that L-CMD, EDMD, and LGMD displayed similar changes. The soleus and the medial and lateral gastrocnemius muscles are the muscles most frequently found to have fatty infiltration. This result was similar to those of other reported imaging studies. [26, 27] The study supported this hypothesis by revealing dynamic muscle MRI changes. L-CMD, EDMD, and LGMD1B are the phenotypes of a continuous entity at different stages; they share the same muscle involvement pattern throughout the disease progression. This information will lead to a way of helping us to further understand this disease and will guide follow-up researches of laminopathies.
Fatty infiltration of the vasti muscles was more frequently found in all phenotypes of the laminopathies, which identified the vasti muscles as a biomarker for evaluating the disease progress. We found that the fatty infiltration score of the vasti muscles is 1.483 + 0.075 × disease duration (X). The infiltration occurred more slowly in patients with DMD, in which the standard deviation of the fatty infiltration scores ranged from 2.41 to 4.87 before 5 years old and from 6.84 to 11.66 between 6 and 10 years old. [34] The study provided important clues for differential diagnosis, especially between L-CMD and juvenile inflammatory myopathy. Myopathologically, most of the L-CMD patients in this study displayed massive inflammatory cell infiltration, as observed in the muscle biopsy, which were easily misdiagnosed as inflammatory myopathy. Previous studies also reported histological findings of inflammation in patients with laminopathies, especially in infants and children. [18, 19, 36, 37] Similar inflammatory changes are not uncommon in other muscular dystrophy diseases including dysferlinopathy, LGMD2I, and facioscapulohumeral muscular dystrophy. [38] [39] [40] [41] Up to now, the exact mechanism how mutant LMNA inducing inflammatory process in skeletal muscle has not been clarified, although one study revealed that nuclear lamina defects can cause the systemic inflammatory response through activating nuclear factor-kappa B signal pathways in HGPS (progeria caused by mutant LMNA) mouse model. [42] In this study, despite the inflammatory changes on muscle pathology, muscle MRI scans did not show any remarkable muscle edema, as is expected in inflammatory myopathies. Muscle MRI in inflammatory myopathies usually showed comprehensive edema as demonstrated by our previous studies and the others. [43, 44] The follow-up studies using muscle imaging in the study also showed more severe fatty infiltration in L-CMD patients instead of edema changes. The reason for the mismatch between the biopsy and muscle imaging findings remains unknown, but it could imply that MRI would be a useful tool for distinguishing laminopathies from myositis.
In conclusion, the present study shows that patients with laminopathies share similar muscle imaging patterns across different phenotypes. We find that fatty infiltration of the vasti muscles is more frequently found in EDMD and
LGMD1B patients compared to L-CMD patients, indicating that the vasti muscles are involved in the advanced stage of the disease. Our results can help guide diagnosis in patients with LMNA mutations and will lead the way for further research.
Supplementary information is linked to the online version of the paper on the Chinese Medical Journal website.
